• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非诺贝特通过下调高脂饮食诱导的 2 型糖尿病模型小鼠的 Runx2 降低骨质量。

Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model.

机构信息

Department of Sports Medicine and Adult Reconstructive Surgery, Drum Tower Hospital, School of Medicine, Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, People's Republic of China.

State Key Laboratory of Pharmaceutical Biotechnology and Jiangsu Key Laboratory of Molecular Medicine and School of Medicine, Nanjing University, No. 22 Hankou Road, Gulou District, Nanjing, Jiangsu Province, 210093, China.

出版信息

Lipids Health Dis. 2017 Oct 13;16(1):201. doi: 10.1186/s12944-017-0592-5.

DOI:10.1186/s12944-017-0592-5
PMID:29029615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5640963/
Abstract

BACKGROUND

This study is to investigate the effect of fenofibrate on the bone quality of Type 2 diabetes mellitus (T2DM) mouse model.

METHODS

T2DM mouse model was induced by high-fat-diet, and the mice were treated with fenofibrate (100 mg/kg) (DIO-FENO) or PBS (DIO-PBS) for 4 weeks. The bone microstructure and biomechanical properties of femora were analyzed by micro-CT and 3-Point bending test. The protein expression was detected by immunohistochemical staining and Western blot. The cell apoptosis was evaluated by TUNEL staining. The Bcl2, caspase 3, and osteoblast marker genes were detected by RT-qPCR.

RESULTS

The biomechanical properties of bones from DIO-FENO group were significantly lower than those in the control and DIO-PBS groups. Besides, the trabecular number was lower than those of the other groups, though the cortical porosity was decreased compared with that of DIO-PBS group because of the increase of apoptotic cells. The expression of osteocalcin and collagen I were decreased after treatment with fenofibrate in T2DM mice. Moreover, the cell viability was decreased after treated with different concentrations of fenofibrate, and the expression of Runx2 decreased after treated with high dose of fenofibrate.

CONCLUSION

Fenofibrate decreases the bone quality of T2DM mice through decreasing the expression of collagen I and osteocalcin, which may be resulted from the down regulation of Runx2 expression.

摘要

背景

本研究旨在探讨非诺贝特对 2 型糖尿病(T2DM)小鼠模型骨质量的影响。

方法

通过高脂肪饮食诱导 T2DM 小鼠模型,并用非诺贝特(100mg/kg)(DIO-FENO)或 PBS(DIO-PBS)处理 4 周。通过 micro-CT 和 3 点弯曲试验分析股骨的骨微结构和生物力学特性。通过免疫组织化学染色和 Western blot 检测蛋白质表达。通过 TUNEL 染色评估细胞凋亡。通过 RT-qPCR 检测 Bcl2、caspase 3 和成骨细胞标志物基因。

结果

DIO-FENO 组的骨生物力学性能明显低于对照组和 DIO-PBS 组。此外,与其他组相比,DIO-FENO 组的骨小梁数量较低,尽管由于凋亡细胞的增加,皮质孔隙率降低。与 DIO-PBS 组相比,在用非诺贝特治疗的 T2DM 小鼠中,骨钙素和胶原 I 的表达降低。此外,用不同浓度的非诺贝特处理后细胞活力降低,用高剂量非诺贝特处理后 Runx2 的表达降低。

结论

非诺贝特通过降低胶原 I 和骨钙素的表达降低 T2DM 小鼠的骨质量,这可能是由于 Runx2 表达下调所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/e312fe19ef83/12944_2017_592_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/e535194e55dd/12944_2017_592_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/9070072ddb3d/12944_2017_592_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/b88c1f455cf8/12944_2017_592_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/e312fe19ef83/12944_2017_592_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/e535194e55dd/12944_2017_592_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/9070072ddb3d/12944_2017_592_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/b88c1f455cf8/12944_2017_592_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e8/5640963/e312fe19ef83/12944_2017_592_Fig4_HTML.jpg

相似文献

1
Fenofibrate decreases the bone quality by down regulating Runx2 in high-fat-diet induced Type 2 diabetes mellitus mouse model.非诺贝特通过下调高脂饮食诱导的 2 型糖尿病模型小鼠的 Runx2 降低骨质量。
Lipids Health Dis. 2017 Oct 13;16(1):201. doi: 10.1186/s12944-017-0592-5.
2
Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and Strength.成骨细胞中BCLXL的过表达抑制成骨细胞凋亡并增加骨体积和骨强度。
J Bone Miner Res. 2016 Jul;31(7):1366-80. doi: 10.1002/jbmr.2808. Epub 2016 Mar 4.
3
Distinct Effects of a High Fat Diet on Bone in Skeletally Mature and Developing Male C57BL/6J Mice.高脂饮食对骨骼成熟和发育中的雄性 C57BL/6J 小鼠的不同影响。
Nutrients. 2021 May 14;13(5):1666. doi: 10.3390/nu13051666.
4
The flavonoid fisetin promotes osteoblasts differentiation through Runx2 transcriptional activity.黄酮类化合物非瑟酮通过Runx2转录活性促进成骨细胞分化。
Mol Nutr Food Res. 2014 Jun;58(6):1239-48. doi: 10.1002/mnfr.201300836. Epub 2014 Feb 18.
5
NIPA2 regulates osteoblast function by modulating mitophagy in type 2 diabetes osteoporosis.NIPA2 通过调节 2 型糖尿病骨质疏松症中的细胞自噬来调节成骨细胞功能。
Sci Rep. 2020 Feb 20;10(1):3078. doi: 10.1038/s41598-020-59743-4.
6
Runx2-Modified Adipose-Derived Stem Cells Promote Tendon Graft Integration in Anterior Cruciate Ligament Reconstruction.Runx2修饰的脂肪来源干细胞促进前交叉韧带重建中肌腱移植物的整合。
Sci Rep. 2016 Jan 8;6:19073. doi: 10.1038/srep19073.
7
Extracellular calcium chronically induced human osteoblasts effects: specific modulation of osteocalcin and collagen type XV.细胞外钙慢性诱导人成骨细胞的作用:骨钙素和型胶原 XV 的特异性调节。
J Cell Physiol. 2012 Aug;227(8):3151-61. doi: 10.1002/jcp.24001.
8
MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway.MiR-378过表达通过靶向半胱天冬酶3(CASP3)并激活PI3K/Akt信号通路来减轻高糖抑制的成骨分化。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7249-61. eCollection 2014.
9
ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells.载脂蛋白E基因缺陷通过刺激成骨细胞中p53介导的细胞凋亡,增强了高脂饮食诱导的骨形成减少。
J Bone Miner Res. 2007 Jul;22(7):1020-30. doi: 10.1359/jbmr.070330.
10
High-fat and high-glucose microenvironment decreases Runx2 and TAZ expression and inhibits bone regeneration in the mouse.高脂高糖微环境降低小鼠体内Runx2和TAZ的表达并抑制骨再生。
J Orthop Surg Res. 2019 Feb 18;14(1):55. doi: 10.1186/s13018-019-1084-2.

引用本文的文献

1
Integrated Phenotypic and Transcriptomic Analyses of Osteoporosis in Type 2 Diabetic Mice.2型糖尿病小鼠骨质疏松症的综合表型和转录组分析
Int J Med Sci. 2025 Mar 10;22(8):1773-1790. doi: 10.7150/ijms.109537. eCollection 2025.
2
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies.脂质修饰干预的多效性:探索传统和新型降血脂疗法
Metabolites. 2024 Jul 17;14(7):388. doi: 10.3390/metabo14070388.
3
Preclinical Rodent Models for Human Bone Disease, Including a Focus on Cortical Bone.

本文引用的文献

1
Correlation of the Lipid Profile, BMI and Bone Mineral Density in Postmenopausal Women.绝经后女性血脂谱、体重指数与骨密度的相关性
Mater Sociomed. 2016 Dec;28(6):412-415. doi: 10.5455/msm.2016.28.412-415.
2
Mechanisms of diabetes mellitus-induced bone fragility.糖尿病性骨脆弱的发病机制。
Nat Rev Endocrinol. 2017 Apr;13(4):208-219. doi: 10.1038/nrendo.2016.153. Epub 2016 Sep 23.
3
Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?2型糖尿病患者常用药物:它们对血脂谱有何影响?
人类骨疾病的临床前啮齿动物模型,包括对皮质骨的关注。
Endocr Rev. 2024 Jul 12;45(4):493-520. doi: 10.1210/endrev/bnae004.
4
The synergistic ameliorative activity of peroxisome proliferator-activated receptor-alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance.过氧化物酶体增殖物激活受体α和γ激动剂非诺贝特和吡格列酮对胰岛素抵抗大鼠模型海马神经退行性变的协同改善作用。
Ibrain. 2022 Aug 8;8(3):251-263. doi: 10.1002/ibra.12059. eCollection 2022 Fall.
5
Bone Health in Patients with Dyslipidemias: An Underestimated Aspect.血脂异常患者的骨骼健康:一个被低估的方面。
Int J Mol Sci. 2022 Jan 31;23(3):1639. doi: 10.3390/ijms23031639.
6
Imaging in experimental models of diabetes.糖尿病实验模型的影像学。
Acta Diabetol. 2022 Feb;59(2):147-161. doi: 10.1007/s00592-021-01826-3. Epub 2021 Nov 15.
7
Exercise improves bone formation by upregulating the Wnt3a/β-catenin signalling pathway in type 2 diabetic mice.运动通过上调2型糖尿病小鼠的Wnt3a/β-连环蛋白信号通路来改善骨形成。
Diabetol Metab Syndr. 2021 Oct 23;13(1):116. doi: 10.1186/s13098-021-00732-6.
8
Inhibition of pyroptosis attenuates -induced bone injury in traumatic osteomyelitis.抑制细胞焦亡可减轻创伤性骨髓炎中 -诱导的骨损伤。 (注:原文中“-induced”前面似乎缺失了某个具体因素,翻译时保留了这种不完整表述)
Ann Transl Med. 2019 Apr;7(8):170. doi: 10.21037/atm.2019.03.40.
9
Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation Through Activating Pparα Pathway.脑心通通过激活过氧化物酶体增殖物激活受体α通路抑制泡沫细胞形成来延缓动脉粥样硬化。
Curr Mol Med. 2018;18(10):698-710. doi: 10.2174/1566524019666190207143207.
Cardiovasc Diabetol. 2016 Jul 14;15:95. doi: 10.1186/s12933-016-0412-7.
4
Type 2 diabetes mellitus.2 型糖尿病。
Nat Rev Dis Primers. 2015 Jul 23;1:15019. doi: 10.1038/nrdp.2015.19.
5
Metformin-associated lactic acidosis: Current perspectives on causes and risk.二甲双胍相关乳酸酸中毒:病因与风险的当前观点
Metabolism. 2016 Feb;65(2):20-9. doi: 10.1016/j.metabol.2015.10.014. Epub 2015 Oct 9.
6
Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes.潜在的药物组合以减少糖尿病患者的心血管疾病负担。
Trends Pharmacol Sci. 2016 Mar;37(3):207-219. doi: 10.1016/j.tips.2015.11.009. Epub 2015 Dec 21.
7
Effects of diabetes drugs on the skeleton.糖尿病药物对骨骼的影响。
Bone. 2016 Jan;82:93-100. doi: 10.1016/j.bone.2015.04.026. Epub 2015 Apr 23.
8
Osteoporosis-associated fracture and diabetes.骨质疏松症相关骨折与糖尿病。
Endocrinol Metab Clin North Am. 2014 Mar;43(1):233-43. doi: 10.1016/j.ecl.2013.09.004. Epub 2013 Dec 10.
9
Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.非诺贝特通过激活 NF-κB 通路诱导三阴性乳腺癌细胞凋亡。
BMC Cancer. 2014 Feb 16;14:96. doi: 10.1186/1471-2407-14-96.
10
Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012.1997 - 2012年美国2型糖尿病的门诊治疗
Diabetes Care. 2014 Apr;37(4):985-92. doi: 10.2337/dc13-2097. Epub 2013 Nov 6.